
Mounjaro Injection in Dubai
A doctor-supervised weekly injection programme.
- Results: Gradual, over months; individual results vary
- Medicine: Tirzepatide, once-weekly injection
- Prescription: Only after a doctor's assessment
- Medicine
- Tirzepatide, once-weekly injection
- Prescription
- Only after a doctor's assessment
- Dose
- Starts low and rises gradually, if your doctor advises
- Results
- Gradual, over months; individual results vary
How Mounjaro works
After you eat, your gut releases hormones that signal fullness and help the body manage blood sugar. Tirzepatide mimics two of them, GLP-1 and GIP. It works on the brain's appetite centres, slows how quickly the stomach empties, and helps insulin respond to food.
In practice, most people feel full on smaller portions and think about food less between meals. Weight loss then comes from eating less, which is why nutrition and protein matter so much during treatment.
Mounjaro was first approved for type 2 diabetes, and tirzepatide is now also used for weight management in adults who meet medical criteria. In the main weight-management trial, people taking it alongside diet and activity changes lost, on average, around 15 to 21 percent of their body weight over 72 weeks, depending on dose. Averages hide a wide range, and individual results vary.

What is tirzepatide?
Tirzepatide is the active medicine inside the Mounjaro injection. It is a single molecule designed to act on two hormone receptors at once: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Both hormones are released naturally by the gut after a meal.
Older weight-loss medicines in this family act on GLP-1 only. Adding GIP is what makes tirzepatide different. Researchers believe the two signals together have a stronger effect on appetite and on how the body handles sugar and fat, which may explain the larger average weight loss seen in trials.
Tirzepatide is given once a week, on the same day each week. Treatment always starts at the lowest dose, and your doctor decides whether and when to increase it, usually after at least 4 weeks at each level.
- Acts on two hormones, GLP-1 and GIP
- Once-weekly injection with a fine pen needle
- A gradual dose increase, supervised by your doctor
Mounjaro and Wegovy compared
Wegovy is a once-weekly injection containing semaglutide, a medicine that acts on the GLP-1 hormone only. It is licensed specifically for weight management in adults who meet medical criteria, and, like Mounjaro, it starts at a low dose that is raised gradually over several months.
The main difference is how they work. Semaglutide acts on one hormone, while tirzepatide acts on two. In a head-to-head trial in adults with obesity, average weight loss was greater with tirzepatide, although both medicines produced meaningful results and individual responses vary widely.
Side effects are similar: mostly nausea, diarrhoea, constipation and indigestion, usually strongest early on and after a dose increase. The right choice depends on your health, your medical history, other medicines and how you respond. Your doctor explains the options and only prescribes what is appropriate for you.
- Wegovy: semaglutide, acts on GLP-1
- Mounjaro: tirzepatide, acts on GLP-1 and GIP
- Both: once a week, gradual dose increase, prescription only
Who it suits, and who should not use it
Usually a good fit
- Adults with a BMI of 30 or more
- Adults with a BMI of 27 or more and a weight-related condition such as high blood pressure, prediabetes or sleep apnoea
- People ready to change eating and activity habits alongside the medicine
- Patients who can attend regular doctor reviews
Speak to your doctor first
- Pregnancy, trying to conceive or breastfeeding
- A personal or family history of medullary thyroid cancer or MEN2
- Past pancreatitis, or severe stomach emptying problems (gastroparesis)
- Type 1 diabetes
- Allergy to tirzepatide or any ingredient
- Under 18, or a history of an eating disorder
Gallbladder disease, diabetic eye disease, kidney problems and medicines such as insulin or the oral contraceptive pill need careful review. Tell your doctor about every medicine you take.
Side effects, honestly
Most side effects affect the stomach and are strongest in the first weeks and after a dose increase. Common ones include nausea, diarrhoea, constipation, vomiting, indigestion, burping, tiredness and a much smaller appetite. Mild redness or itching at the injection site can happen too.
Eating smaller meals, stopping when you feel full, drinking enough water and limiting fatty or very sweet food all help. Your doctor will not increase the dose until you are comfortable.
Rarely, more serious problems can occur, including inflammation of the pancreas, gallstones, dehydration that affects the kidneys, and allergic reactions. Seek medical help straight away for severe, persistent stomach pain that may spread to the back, or for swelling of the face or throat.
- Tablet contraceptives may work less well for 4 weeks after starting and after each dose increase: your doctor will advise on extra protection
- Muscle can be lost along with fat, so we track it with InBody and set protein and activity targets
- Weight often returns after stopping if habits have not changed
Mounjaro or Ozempic?
Both are weekly injections from the same family of medicines, and people often ask how they differ. Your doctor decides which, if either, is appropriate.
| Mounjaro | Ozempic | |
|---|---|---|
| Active medicine | Tirzepatide | Semaglutide |
| Hormones it acts on | GLP-1 and GIP | GLP-1 |
| How often | Once a week | Once a week |
| Licensed use | Type 2 diabetes; tirzepatide is also used for weight management | Type 2 diabetes |
| Weight loss in trials | In a head-to-head study, average weight loss was greater with tirzepatide | Meaningful average weight loss, lower than tirzepatide in that study |
| Common side effects | Nausea, diarrhoea, constipation, indigestion | Nausea, diarrhoea, constipation, indigestion |
From consultation to first dose
- 01
Free consultation and InBody
We record your weight, body fat, muscle and visceral fat, and listen to your goals and what you have tried before.
- 02
Medical assessment
Your doctor reviews your history, medicines and any blood tests, checks the reasons you should not use it, and decides whether it is appropriate.
- 03
Prescription and teaching
If prescribed, you start on the lowest dose. We show you how to use the pen and how to handle early side effects.
- 04
Reviews and dose decisions
At each review your doctor looks at progress, side effects and InBody results before any change in dose.
- 05
A plan for afterwards
Your doctor plans how to reduce or stop treatment and which habits will help you keep your result.
Cost of Weekly Weight Loss Injection Programme in Dubai
Clear prices, agreed before you start. Your plan and any package are confirmed by your doctor at a free consultation.
- Free doctor consultation
- InBody analysis included
- No obligation to book
The cost depends on your doctor’s assessment and the plan agreed with you. Your doctor explains every cost at your free consultation, before anything is prescribed.
Prices in AED, exclusive of 5% VAT. Final pricing is confirmed after your consultation.
Your questions,
answered
The cost depends on your doctor's assessment and your plan, including whether the medicine is appropriate for you and how your dose may change over time. Your doctor explains the full cost at the free consultation, before anything is prescribed. Prices exclude VAT.
The Mounjaro injection is given once a week under the skin of the belly, thigh or upper arm, using a pen with a very fine needle. Most people feel only a small scratch. We show you how to inject before your first dose and answer any questions at your reviews.
No. Wegovy contains semaglutide, which acts on GLP-1 only. Mounjaro contains tirzepatide, which acts on GLP-1 and GIP. Both are once-weekly prescription injections, and your doctor explains which, if either, suits you.
Yes. It is a prescription-only medicine. At SlimSculpt you see a doctor first, and it is only prescribed when it is medically appropriate for you.
Many people notice a smaller appetite in the first week or two. Weight loss is usually gradual and continues over several months as the dose is adjusted. Results vary from person to person.
Nausea, diarrhoea, constipation, vomiting, indigestion and a reduced appetite are the most common. They are usually worst early on and after a dose increase, and often ease with time.
It is not used in pregnancy or breastfeeding, with a personal or family history of medullary thyroid cancer or MEN2, after pancreatitis, or in type 1 diabetes. Your doctor checks these and other conditions before prescribing.
Appetite usually returns after stopping, and weight can come back without lasting changes to eating and activity. Your doctor plans a gradual exit and ongoing support.

Get a treatment plan
for your body goals
Book your free
consultation online
Choose a day and time that suits you. Your consultation includes a doctor assessment and InBody analysis, with no obligation to book treatment.
You are booking:
New patient? Mention the 20% first-visit offer when you book.
- Open every day, 10 a.m. to 9:30 p.m.
- Mercato Mall, Jumeirah Beach Road
- Free consultation with InBody analysis
Visit us
in Mercato
Our Jumeirah clinic is inside Mercato Mall on Jumeirah Beach Road, with mall parking on site.
Jumeirah Beach Road, Dubai
Monday to Sunday, 10 a.m. to 9:30 p.m.





